Assessment of the Bioactivity of Antibodies against β-Amyloid Peptide in vitro and in vivo

Publisher： Karger

E-ISSN： 1660-2862|1|4-5|160-167

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.1, Iss.4-5, 2004-11, pp. : 160-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro neurotoxicity of amyloid β-peptide cross-linked by transglutaminase

By Shinagawa R.   Masuda S.   Sasaki R.   Ikura K.   Takahata K.  

Cytotechnology, Vol. 23, Iss. 1-3, 1997-01 ,pp. : 77-85

Springer Publishing Company

Access to resources Recommend Favorite

Control of Amyloid-β-Peptide Generation by Subcellular Trafficking of the β-Amyloid Precursor Protein and β-Secretase

By  

Neurodegenerative Diseases, Vol. 3, Iss. 4-5, 2006-10 ,pp. : 247-254

Karger

Access to resources Recommend Favorite

Potent β-Amyloid Modulators

By  

Neurodegenerative Diseases, Vol. 5, Iss. 3-4, 2008-03 ,pp. : 153-156

Karger

Access to resources Recommend Favorite

Protective effects of Glycyrrhiza uralensis Fisch. on the cognitive deficits caused by β-amyloid peptide 25–35 in young mice

By Ahn J.   Um M.   Choi W.   Kim S.   Ha T.  

Biogerontology, Vol. 7, Iss. 4, 2006-08 ,pp. : 239-247

Springer Publishing Company

Access to resources Recommend Favorite

Donepezil Eliminates Suppressive Effects of β-Amyloid Peptide (1-42) on Long-Term Potentiation in the Hippocampus

By Kapai N.   Solntseva E.   Skrebitskii V.  

Bulletin of Experimental Biology and Medicine, Vol. 149, Iss. 1, 2010-07 ,pp. : 33-36

Springer Publishing Company

Access to resources Recommend Favorite